Annual Cash & Cash Equivalents
$110.00 M
+$55.37 M+101.36%
November 30, 2024
Summary
- As of February 8, 2025, NRIX annual cash & cash equivalents is $110.00 million, with the most recent change of +$55.37 million (+101.36%) on November 30, 2024.
- During the last 3 years, NRIX annual cash & cash equivalents has risen by +$29.49 million (+36.63%).
- NRIX annual cash & cash equivalents is now -7.84% below its all-time high of $119.36 million, reached on November 30, 2020.
Performance
NRIX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$110.00 M
+$10.95 M+11.06%
November 30, 2024
Summary
- As of February 8, 2025, NRIX quarterly cash and cash equivalents is $110.00 million, with the most recent change of +$10.95 million (+11.06%) on November 30, 2024.
- Over the past year, NRIX quarterly cash and cash equivalents has increased by +$60.18 million (+120.82%).
- NRIX quarterly cash and cash equivalents is now -58.57% below its all-time high of $265.53 million, reached on August 31, 2020.
Performance
NRIX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NRIX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +101.4% | +120.8% |
| 3 y3 years | +36.6% | +227.7% |
| 5 y5 years | +215.9% | +227.7% |
NRIX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +101.4% | -5.8% | +227.7% |
| 5 y | 5-year | -7.8% | +215.9% | -58.6% | +227.7% |
| alltime | all time | -7.8% | +329.8% | -58.6% | +227.7% |
Nurix Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | $110.00 M(+101.4%) | $110.00 M(+11.1%) |
| Aug 2024 | - | $99.04 M(-15.2%) |
| May 2024 | - | $116.79 M(+134.5%) |
| Feb 2024 | - | $49.81 M(-8.8%) |
| Nov 2023 | $54.63 M(-15.3%) | $54.63 M(+29.1%) |
| Aug 2023 | - | $42.30 M(-28.2%) |
| May 2023 | - | $58.96 M(+75.6%) |
| Feb 2023 | - | $33.57 M(-47.9%) |
| Nov 2022 | $64.47 M | $64.47 M(+35.6%) |
| Aug 2022 | - | $47.56 M(+14.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| May 2022 | - | $41.53 M(-47.3%) |
| Feb 2022 | - | $78.78 M(-2.1%) |
| Nov 2021 | $80.51 M(-32.5%) | $80.51 M(-45.4%) |
| Aug 2021 | - | $147.44 M(-21.7%) |
| May 2021 | - | $188.21 M(+48.9%) |
| Feb 2021 | - | $126.38 M(+5.9%) |
| Nov 2020 | $119.36 M(+242.8%) | $119.36 M(-55.0%) |
| Aug 2020 | - | $265.53 M(+66.7%) |
| May 2020 | - | $159.33 M(+357.6%) |
| Nov 2019 | $34.82 M(+36.0%) | $34.82 M |
| Nov 2018 | $25.59 M | - |
FAQ
- What is Nurix Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Nurix Therapeutics?
- What is Nurix Therapeutics annual cash & cash equivalents year-on-year change?
- What is Nurix Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Nurix Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of NRIX is $110.00 M
What is the all time high annual cash & cash equivalents for Nurix Therapeutics?
Nurix Therapeutics all-time high annual cash & cash equivalents is $119.36 M
What is Nurix Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, NRIX annual cash & cash equivalents has changed by +$55.37 M (+101.36%)
What is Nurix Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NRIX is $110.00 M
What is the all time high quarterly cash and cash equivalents for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly cash and cash equivalents is $265.53 M
What is Nurix Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, NRIX quarterly cash and cash equivalents has changed by +$60.18 M (+120.82%)